ArticleClinical and vaccine immunology : CVI2007
The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant.
Thomas Ebensen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papercites it